Doctor profile · Federal record
Dr. Vodur Reddy, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Reno, NV
- NPI 1538109004
- Accepts Medicare
- MIPS 69.9 / 100 · 2023
- 30 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5423 Reno Corporate Dr
Reno, NV 895112250
(775) 329-0873
fax (775) 329-1026
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- September 10, 2019
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Nevada #10111
- Medicaid
- NV #2016932
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1538109004. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
31,618
Distinct HCPCS
10
Medicare allowed
$1,315,967
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 9,180 | 17 | $47 | |
J9271 |
Injection, pembrolizumab, 1 mg | 7,800 | 20 | $54 | |
J0897 |
Injection, denosumab, 1 mg | 3,960 | 18 | $23 | |
J0894 |
Injection, decitabine, 1 mg | 1,800 | 13 | $2 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,388 | 54 | $0 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,121 | 463 | $128 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,060 | 40 | $1 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 898 | 328 | $8 | |
36415 |
Insertion of needle into vein for collection of blood sample | 842 | 319 | $8 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 472 | 12 | $0 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 1,102. This provider delivers 29× the peer median.Open Payments
Industry payments received
All-time total
$832
Transactions
25
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $83.11 | |
| Novartis Pharmaceuticals Corporation | 3 | $75.84 | |
| Daiichi Sankyo Inc. | 3 | $62.38 | |
| SpringWorks Therapeutics, Inc. | 2 | $58.26 | |
| Mirati Therapeutics, Inc. | 2 | $49.99 | |
| GlaxoSmithKline, LLC. | 2 | $49.33 | |
| Incyte Corporation | 2 | $45.33 | |
| Janssen Biotech, Inc. | 1 | $34.77 | |
| AstraZeneca Pharmaceuticals LP | 1 | $29.43 | |
| BeiGene USA, Inc. | 1 | $28.73 | |
| Merck Sharp & Dohme LLC | 1 | $28.59 | |
| Kyowa Kirin, Inc. | 1 | $28.30 | |
| PharmaEssentia USA Corporation | 1 | $27.57 | |
| TAIHO ONCOLOGY, INC. | 1 | $27.54 | |
| Alexion Pharmaceuticals, Inc. | 1 | $25.13 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
703
Patients
73
Total drug cost
$1,412,319
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 239 | 55 | $5,552 |
| Hydroxyurea | Generic | 77 | 18 | $2,435 |
| Eliquis (Apixaban) | Brand | 58 | 0 | $41,507 |
| Acyclovir | Generic | 49 | 0 | $1,015 |
| Letrozole | Generic | 45 | 0 | $756 |
| Pomalyst (Pomalidomide) | Brand | 34 | 0 | $845,610 |
| Xarelto (Rivaroxaban) | Brand | 32 | 0 | $20,247 |
| Brukinsa (Zanubrutinib) | Brand | 26 | 0 | $398,155 |
| Levothyroxine Sodium | Generic | 25 | 0 | $263 |
| Tramadol Hcl | Generic | 25 | 0 | $393 |
Hospital affiliations
Frequently asked questions
What is Dr. Vodur Reddy's medical specialty?
Dr. Vodur Reddy practices Hematology & Oncology Physician in Reno, NV.
Where does Dr. Vodur Reddy practice?
Dr. Vodur Reddy practices at 5423 Reno Corporate Dr, Reno, NV 895112250. Office phone: 7753290873.
What is Dr. Vodur Reddy's NPI?
Dr. Vodur Reddy's National Provider Identifier (NPI) is 1538109004, issued by NPPES.
Does Dr. Vodur Reddy accept Medicare assignment?
Yes. Dr. Vodur Reddy accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Vodur Reddy commonly perform?
Top Medicare-reported procedures in 2023: Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.